DK353788A - Polypeptide - Google Patents

Polypeptide

Info

Publication number
DK353788A
DK353788A DK353788A DK353788A DK353788A DK 353788 A DK353788 A DK 353788A DK 353788 A DK353788 A DK 353788A DK 353788 A DK353788 A DK 353788A DK 353788 A DK353788 A DK 353788A
Authority
DK
Denmark
Prior art keywords
polypeptide
Prior art date
Application number
DK353788A
Other languages
Danish (da)
Other versions
DK353788D0 (en
Inventor
Albert Rainer
Wilfried Bauer
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK353788D0 publication Critical patent/DK353788D0/en
Publication of DK353788A publication Critical patent/DK353788A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK353788A 1987-06-29 1988-06-27 Polypeptide DK353788A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3721406 1987-06-29
DE3721407 1987-06-29

Publications (2)

Publication Number Publication Date
DK353788D0 DK353788D0 (en) 1988-06-27
DK353788A true DK353788A (en) 1988-12-30

Family

ID=25857047

Family Applications (1)

Application Number Title Priority Date Filing Date
DK353788A DK353788A (en) 1987-06-29 1988-06-27 Polypeptide

Country Status (15)

Country Link
JP (1) JPS6426599A (en)
KR (1) KR890000520A (en)
AU (1) AU1840988A (en)
BE (1) BE1002663A4 (en)
CH (1) CH679045A5 (en)
DK (1) DK353788A (en)
ES (1) ES2010283A6 (en)
FR (1) FR2617171B1 (en)
GB (1) GB2206352B (en)
IL (1) IL86876A0 (en)
IT (1) IT1221065B (en)
LU (1) LU87262A1 (en)
NL (1) NL8801640A (en)
NZ (1) NZ225188A (en)
SE (1) SE8802413L (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206890B (en) * 1986-10-13 1993-01-28 Sandoz Ag Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components
GB8826452D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Peptide derivatives
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
US5776894A (en) * 1988-12-05 1998-07-07 Novartis Ag Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
US5753627A (en) * 1988-12-05 1998-05-19 Novartis Ag Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
JP2882679B2 (en) * 1989-04-26 1999-04-12 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド Linear somatostatin analog
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
AUPN999096A0 (en) * 1996-05-22 1996-06-13 Northstar Biologicals Pty Ltd Peptides, antibodies, vaccines & uses thereof
CA2385910A1 (en) * 2000-07-31 2002-02-07 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
DE60226419D1 (en) 2001-03-08 2008-06-19 Univ Tulane SOMATOSTATIN ANTAGONISTS
MXPA03009048A (en) * 2001-04-09 2004-02-12 Univ Tulane Somatostatin agonists.
KR100432178B1 (en) * 2002-01-29 2004-05-22 홍수천 Apparatus for purifying water capable of preventing corrosion of iron-based pipeline
KR100462968B1 (en) * 2002-06-10 2004-12-23 주식회사 리독스 Water treatment apparatus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85269A1 (en) * 1984-03-26 1985-10-14 Techland S A NOVEL SOMATOSTATIN COMPOUNDS, PROCESS FOR THEIR SYNTHESIS, PREPARATION FOR VETERINARY USE CONTAINING SAID COMPOUNDS AND PROCESS FOR THE TREATMENT OF ANIMALS
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds

Also Published As

Publication number Publication date
SE8802413L (en) 1988-12-30
SE8802413D0 (en) 1988-06-28
CH679045A5 (en) 1991-12-13
DK353788D0 (en) 1988-06-27
KR890000520A (en) 1989-03-15
BE1002663A4 (en) 1991-04-30
NL8801640A (en) 1989-01-16
FR2617171B1 (en) 1994-10-14
GB2206352A (en) 1989-01-05
FR2617171A1 (en) 1988-12-30
GB8815257D0 (en) 1988-08-03
IT8848133A0 (en) 1988-06-28
IT1221065B (en) 1990-06-21
JPS6426599A (en) 1989-01-27
AU1840988A (en) 1989-01-05
IL86876A0 (en) 1988-11-30
NZ225188A (en) 1991-04-26
ES2010283A6 (en) 1989-11-01
GB2206352B (en) 1990-10-31
LU87262A1 (en) 1989-03-08

Similar Documents

Publication Publication Date Title
DK97790A (en) PURE-INHIBITIVE PEPTIDES
ATA30988A (en) ALPINSKI
LV10019A (en) Herbicida composed
ATA174488A (en) ALPINSKI
DK275788D0 (en) PROTEIN
ATA174288A (en) ALPINSKI
DK353788A (en) Polypeptide
ATA224788A (en) CALCITON INSUPPOSITORIES
DK354389D0 (en) POLYPEPTIDE
DK492588A (en) MEROZOIT-ANTIGEN POLYPEPTIDES
ATA48687A (en) GUELLEFASS
AT389045B (en) PARAOCCLUSAL LOEFFEL
ATA294988A (en) HAECKSLER
DK596888D0 (en) RECOMBINANT LYMO PHOTOXIN
DK624089D0 (en) polypeptide
AT388649B (en) SPORTSHOE
ATA162787A (en) HOERGERAET
DK341687D0 (en) POLYPEPTIDES
DK101587D0 (en) PEPTIDES
BR1100729A (en) Modified polypeptide
IT8719414V0 (en) CROMAGIC T
BR6700736U (en) CLOSE
BR6701734U (en) AMNIOSCOPIO
BR6701063U (en) BASKET-SAFE
ATA257287A (en) GLYCOPEPTIDANTIBIOTICS

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment